Book contents
- Movement Disorders and Inherited Metabolic Disorders
- Movement Disorders and Inherited Metabolic Disorders
- Copyright page
- Dedication
- Contents
- Contributors
- Preface
- Acknowledgments
- Section I General Principles and a Phenomenology-Based Approach to Movement Disorders and Inherited Metabolic Disorders
- Section II A Metabolism-Based Approach to Movement Disorders and Inherited Metabolic Disorders
- Chapter 12 Disorders of Amino Acid Metabolism: Amino Acid Disorders, Organic Acidurias, and Urea Cycle Disorders with Movement Disorders
- Chapter 13 Disorders of Energy Metabolism: GLUT1 Deficiency Syndrome and Movement Disorders
- Chapter 14 Lysosomal Storage Disorders: Niemann–Pick Disease Type C and Movement Disorders
- Chapter 15 Lysosomal Storage Disorders: Neuronal Ceroid Lipofuscinoses and Movement Disorders
- Chapter 16 Syndromes of Neurodegeneration with Brain Iron Accumulation
- Chapter 17 Metal Storage Disorders: Inherited Disorders of Copper and Manganese Metabolism and Movement Disorders
- Chapter 18 Metal Storage Disorders: Primary Familial Brain Calcification and Movement Disorders
- Chapter 19 Disorders of Glycosylation and Movement Disorders
- Chapter 20 Disorders of Post-Translational Modifications/Degradation: Autophagy and Movement Disorders
- Chapter 21 Neurotransmitter Disorders: Disorders of Dopamine Metabolism and Movement Disorders
- Chapter 22 Neurotransmitter Disorders: DNAJC12-Deficient Hyperphenylalaninemia – An Emerging Neurotransmitter Disorder
- Chapter 23 Neurotransmitter Disorders: Disorders of GABA Metabolism and Movement Disorders
- Chapter 24 Vitamin-Responsive Disorders: Ataxia with Vitamin E Deficiency and Movement Disorders
- Chapter 25 Vitamin-Responsive Disorders: Biotin–Thiamine-Responsive Basal Ganglia Disease and Movement Disorders
- Chapter 26 Disorders of Cholesterol Metabolism: Cerebrotendinous Xanthomatosis and Movement Disorders
- Chapter 27 Purine Metabolism Defects: The Movement Disorder of Lesch–Nyhan Disease
- Chapter 28 Disorders of Creatine Metabolism: Creatine Deficiency Syndromes and Movement Disorders
- Chapter 29 Hereditary Spastic Paraplegia-Related Inborn Errors of Metabolism
- Section III Conclusions and Future Directions
- Appendix: Video Captions
- Index
- References
Chapter 24 - Vitamin-Responsive Disorders: Ataxia with Vitamin E Deficiency and Movement Disorders
from Section II - A Metabolism-Based Approach to Movement Disorders and Inherited Metabolic Disorders
Published online by Cambridge University Press: 24 September 2020
Book contents
- Movement Disorders and Inherited Metabolic Disorders
- Movement Disorders and Inherited Metabolic Disorders
- Copyright page
- Dedication
- Contents
- Contributors
- Preface
- Acknowledgments
- Section I General Principles and a Phenomenology-Based Approach to Movement Disorders and Inherited Metabolic Disorders
- Section II A Metabolism-Based Approach to Movement Disorders and Inherited Metabolic Disorders
- Chapter 12 Disorders of Amino Acid Metabolism: Amino Acid Disorders, Organic Acidurias, and Urea Cycle Disorders with Movement Disorders
- Chapter 13 Disorders of Energy Metabolism: GLUT1 Deficiency Syndrome and Movement Disorders
- Chapter 14 Lysosomal Storage Disorders: Niemann–Pick Disease Type C and Movement Disorders
- Chapter 15 Lysosomal Storage Disorders: Neuronal Ceroid Lipofuscinoses and Movement Disorders
- Chapter 16 Syndromes of Neurodegeneration with Brain Iron Accumulation
- Chapter 17 Metal Storage Disorders: Inherited Disorders of Copper and Manganese Metabolism and Movement Disorders
- Chapter 18 Metal Storage Disorders: Primary Familial Brain Calcification and Movement Disorders
- Chapter 19 Disorders of Glycosylation and Movement Disorders
- Chapter 20 Disorders of Post-Translational Modifications/Degradation: Autophagy and Movement Disorders
- Chapter 21 Neurotransmitter Disorders: Disorders of Dopamine Metabolism and Movement Disorders
- Chapter 22 Neurotransmitter Disorders: DNAJC12-Deficient Hyperphenylalaninemia – An Emerging Neurotransmitter Disorder
- Chapter 23 Neurotransmitter Disorders: Disorders of GABA Metabolism and Movement Disorders
- Chapter 24 Vitamin-Responsive Disorders: Ataxia with Vitamin E Deficiency and Movement Disorders
- Chapter 25 Vitamin-Responsive Disorders: Biotin–Thiamine-Responsive Basal Ganglia Disease and Movement Disorders
- Chapter 26 Disorders of Cholesterol Metabolism: Cerebrotendinous Xanthomatosis and Movement Disorders
- Chapter 27 Purine Metabolism Defects: The Movement Disorder of Lesch–Nyhan Disease
- Chapter 28 Disorders of Creatine Metabolism: Creatine Deficiency Syndromes and Movement Disorders
- Chapter 29 Hereditary Spastic Paraplegia-Related Inborn Errors of Metabolism
- Section III Conclusions and Future Directions
- Appendix: Video Captions
- Index
- References
Summary
Ataxia with vitamin E deficiency (AVED) was first described in 1981 by Burck et al. [1] as a progressive cerebellar ataxia in a 12-year-old boy with low vitamin E levels and without any alternative diagnosis.
- Type
- Chapter
- Information
- Movement Disorders and Inherited Metabolic DisordersRecognition, Understanding, Improving Outcomes, pp. 307 - 313Publisher: Cambridge University PressPrint publication year: 2020
References
Burck, U, Goebel, HH, Kuhlendahl, HD, Meier, C, Goebel, KM. Neuromyopathy and vitamin E deficiency in man. Neuropediatrics. 1981;12(3):267–78.Google Scholar
Ben Hamida, M, Belal, S, Sirugo, G, et al. Friedreich’s ataxia phenotype not linked to chromosome 9 and associated with selective autosomal recessive vitamin E deficiency in two inbred Tunisian families. Neurology. 1993;43(11):2179–83.Google Scholar
Ben Hamida, C, Doerflinger, N, Belal, S, et al. Localization of Friedreich ataxia phenotype with selective vitamin E deficiency to chromosome 8q by homozygosity mapping. Nat Genet. 1993;5(2):195–200.CrossRefGoogle ScholarPubMed
Ouahchi, K, Arita, M, Kayden, H, et al. Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein. Nat Genet. 1995;9(2):141–5.Google Scholar
Mocchegiani, E, Costarelli, L, Giacconi, R, et al. Vitamin E–gene interactions in aging and inflammatory age-related diseases: Implications for treatment. A systematic review. Ageing Res Rev. 2014;14:81–101.Google Scholar
Ulatowski, L, Parker, R, Warrier, G, et al. Vitamin E is essential for Purkinje neuron integrity. Neuroscience. 2014;260:120–9.CrossRefGoogle ScholarPubMed
Arita, M, Sato, Y, Miyata, A, et al. Human alpha-tocopherol transfer protein: cDNA cloning, expression and chromosomal localization. Biochem J. 1995;306 ( Pt 2):437–43.CrossRefGoogle ScholarPubMed
Harding, AE, Matthews, S, Jones, S, et al. Spinocerebellar degeneration associated with a selective defect of vitamin E absorption. N Engl J Med. 1985;313(1):32–5.Google Scholar
Yokota, T, Wada, Y, Furukawa, T, et al. Adult-onset spinocerebellar syndrome with idiopathic vitamin E deficiency. Ann Neurol. 1987;22(1):84–7.CrossRefGoogle ScholarPubMed
El Euch-Fayache, G, Bouhlal, Y, Amouri, R, Feki, M, Hentati, F. Molecular, clinical and peripheral neuropathy study of Tunisian patients with ataxia with vitamin E deficiency. Brain. 2014;137(Pt 2):402–10.Google Scholar
Marzouki, N, Benomar, A, Yahyaoui, M, et al. Vitamin E deficiency ataxia with (744 del A) mutation on alpha-TTP gene: Genetic and clinical peculiarities in Moroccan patients. Eur J Med Genet. 2005;48(1):21–8.Google Scholar
Doerflinger, N, Linder, C, Ouahchi, K, et al. Ataxia with vitamin E deficiency: Refinement of genetic localization and analysis of linkage disequilibrium by using new markers in 14 families. Am J Hum Genet. 1995;56(5):1116–24.Google ScholarPubMed
Benomar, A, Yahyaoui, M, Meggouh, F, et al. Clinical comparison between AVED patients with 744 del A mutation and Friedreich ataxia with GAA expansion in 15 Moroccan families. J Neurol Sci. 2002; 198 (1–2): 25–9.Google Scholar
Bouhlal, Y, Zouari, M, Kefi, M, et al. Autosomal recessive ataxia caused by three distinct gene defects in a single consanguineous family. J Neurogenet. 2008;22(2):139-48.CrossRefGoogle Scholar
Cavalier, L, Ouahchi, K, Kayden, HJ, et al. Ataxia with isolated vitamin E deficiency: Heterogeneity of mutations and phenotypic variability in a large number of families. Am J Hum Genet. 1998;62(2):301–10.CrossRefGoogle Scholar
Mariotti, C, Gellera, C, Rimoldi, M, et al. Ataxia with isolated vitamin E deficiency: Neurological phenotype, clinical follow-up and novel mutations in TTPA gene in Italian families. Neurol Sci. 2004;25(3):130–7.CrossRefGoogle ScholarPubMed
Hentati, A, Deng, HX, Hung, WY, et al. Human alpha-tocopherol transfer protein: Gene structure and mutations in familial vitamin E deficiency. Ann Neurol. 1996;39(3):295–300.Google Scholar
Gotoda, T, Arita, M, Arai, H, et al. Adult-onset spinocerebellar dysfunction caused by a mutation in the gene for the alpha-tocopherol-transfer protein. N Engl J Med. 1995;333(20):1313–8.Google Scholar
Di Donato, I, Bianchi, S, Federico, A. Ataxia with vitamin E deficiency: Update of molecular diagnosis. Neurol Sci. 2010;31(4):511–5.CrossRefGoogle ScholarPubMed
Hamza, W, Ali Pacha, L, Hamadouche, T, et al. Molecular and clinical study of a cohort of 110 Algerian patients with autosomal recessive ataxia. BMC Med Genet. 2015;16:36.Google Scholar
Zortea, M, Armani, M, Pastorello, E, et al. Prevalence of inherited ataxias in the province of Padua, Italy. Neuroepidemiology. 2004;23(6):275–80.Google Scholar
Anheim, M, Fleury, M, Monga, B, et al. Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: Implications for clinical management. Neurogenetics. 2010;11(1):1–12.Google Scholar
Elkamil, A, Johansen, KK, Aasly, J. Ataxia with vitamin E deficiency in Norway. J Mov Disord. 2015;8(1):33–6.Google Scholar
Bonello, M, Ray, P. A case of ataxia with isolated vitamin E deficiency initially diagnosed as Friedreich’s ataxia. Case Rep Neurol Med. 2016;2016:8342653.Google Scholar
Schuelke, M, Finckh, B, Sistermans, EA, et al. Ataxia with vitamin E deficiency: Biochemical effects of malcompliance with vitamin E therapy. Neurology. 2000;55(10):1584–6.CrossRefGoogle ScholarPubMed
Angelini, L, Erba, A, Mariotti, C, et al. Myoclonic dystonia as unique presentation of isolated vitamin E deficiency in a young patient. Mov Disord. 2002;17(3):612–4.Google Scholar
Amiel, J, Maziere, JC, Beucler, I, et al. Familial isolated vitamin E deficiency. Extensive study of a large family with a 5-year therapeutic follow-up. J Inherit Metab Dis. 1995;18(3):333–40.Google Scholar
Krendel, DA, Gilchrist, JM, Johnson, AO, Bossen, EH. Isolated deficiency of vitamin E with progressive neurologic deterioration. Neurology. 1987;37(3):538–40.Google Scholar
Stumpf, DA, Sokol, R, Bettis, D, et al. Friedreich’s disease: V. Variant form with vitamin E deficiency and normal fat absorption. Neurology. 1987;37(1):68–74.CrossRefGoogle ScholarPubMed
Becker, AE, Vargas, W, Pearson, TS. Ataxia with vitamin E deficiency may present with cervical dystonia. Tremor Other Hyperkinet Mov (NY). 2016;6:374.Google Scholar
Roubertie, A, Biolsi, B, Rivier, F, et al. Ataxia with vitamin E deficiency and severe dystonia: Report of a case. Brain Dev. 2003;25(6):442–5.Google Scholar
Hoshino, M, Masuda, N, Ito, Y, et al. Ataxia with isolated vitamin E deficiency: A Japanese family carrying a novel mutation in the alpha-tocopherol transfer protein gene. Ann Neurol. 1999;45(6):809–12.Google Scholar
Pang, J, Kiyosawa, M, Seko, Y, et al. Clinicopathological report of retinitis pigmentosa with vitamin E deficiency caused by mutation of the alpha-tocopherol transfer protein gene. Jpn J Ophthalmol. 2001;45(6):672–6.Google Scholar
Shimohata, T, Date, H, Ishiguro, H, et al. Ataxia with isolated vitamin E deficiency and retinitis pigmentosa. Ann Neurol. 1998;43(2):273.Google Scholar
Usuki, F, Maruyama, K. Ataxia caused by mutations in the alpha-tocopherol transfer protein gene. J Neurol Neurosurg Psychiatry. 2000;69(2):254–6.Google Scholar
Yokota, T, Shiojiri, T, Gotoda, T, et al. Friedreich-like ataxia with retinitis pigmentosa caused by the His101Gln mutation of the alpha-tocopherol transfer protein gene. Ann Neurol. 1997;41(6):826–32.Google Scholar
Iwasa, K, Shima, K, Komai, K, et al. Retinitis pigmentosa and macular degeneration in a patient with ataxia with isolated vitamin E deficiency with a novel c.717 del C mutation in the TTPA gene. J Neurol Sci. 2014; 345 (1-2): 228–30.Google Scholar
Kara, B, Uzumcu, A, Uyguner, O, et al. Ataxia with vitamin E deficiency associated with deafness. Turk J Pediatr. 2008;50(5):471–5.Google Scholar
Rossato, M, Mariotti, C. Normal spermatogenesis and sperm function in a subject affected by cerebellar ataxia due to congenital vitamin E deficiency. Andrologia. 2014;46(3):322–4.Google Scholar
Mansoor, S, Ahmad, A. Progressive ataxia due to alpha-tocopherol deficiency in Pakistan. Iran J Neurol. 2016;15(2):103–5.Google Scholar
Muller, KI, Bekkelund, SI. Epilepsy in a patient with ataxia caused by vitamin E deficiency. BMJ Case Rep. 2011;doi:10.1136/bcr.01.2011.3728.Google Scholar
Larnaout, A, Belal, S, Zouari, M, et al. Friedreich’s ataxia with isolated vitamin E deficiency: A neuropathological study of a Tunisian patient. Acta Neuropathol. 1997;93(6):633–7.CrossRefGoogle ScholarPubMed
Yokota, T, Uchihara, T, Kumagai, J, et al. Postmortem study of ataxia with retinitis pigmentosa by mutation of the alpha-tocopherol transfer protein gene. J Neurol Neurosurg Psychiatry. 2000;68(4):521–5.Google Scholar
Durr, A, Cossee, M, Agid, Y, et al. Clinical and genetic abnormalities in patients with Friedreich’s ataxia. N Engl J Med. 1996;335(16):1169–75.Google Scholar
Ponten, SC, Kwee, ML, Wolters, E, Zijlmans, JC. First case of ataxia with isolated vitamin E deficiency in the Netherlands. Parkinsonism Relat Disord. 2007;13(5):315–6.Google Scholar
Doria-Lamba, L, De Grandis, E, Cristiani, E, et al. Efficacious vitamin E treatment in a child with ataxia with isolated vitamin E deficiency. Eur J Pediatr. 2006;165(7):494–5.Google Scholar
Gabsi, S, Gouider-Khouja, N, Belal, S, et al. Effect of vitamin E supplementation in patients with ataxia with vitamin E deficiency. Eur J Neurol. 2001;8(5):477–81.Google Scholar
Schuelke, M, Mayatepek, E, Inter, M, et al. Treatment of ataxia in isolated vitamin E deficiency caused by alpha-tocopherol transfer protein deficiency. J Pediatr. 1999;134(2):240–4.Google Scholar
Zelante, G, Patti, F, Vinciguerra, L, Gellera, C, Zappia, M. Ataxia with vitamin E deficiency caused by a new compound heterozygous mutation. Neurol Sci. 2016;37(9):1571–2.Google Scholar
Koht, J, Bjornara, KA, Jorum, E, Tallaksen, CM. Ataxia with vitamin E deficiency in southeast Norway, case report. Acta Neurol Scand Suppl. 2009(189):42–5.Google Scholar
Cellini, E, Piacentini, S, Nacmias, B, et al. A family with spinocerebellar ataxia type 8 expansion and vitamin E deficiency ataxia. Arch Neurol. 2002;59(12):1952–3.Google Scholar
Martinello, F, Fardin, P, Ottina, M, et al. Supplemental therapy in isolated vitamin E deficiency improves the peripheral neuropathy and prevents the progression of ataxia. J Neurol Sci. 1998;156(2):177–9.Google Scholar
Tamaru, Y, Hirano, M, Kusaka, H, et al. Alpha-tocopherol transfer protein gene: Exon skipping of all transcripts causes ataxia. Neurology. 1997;49(2):584–8.Google Scholar